Simvastatin prompts the apoptosis of human colon cancer cells and inhibits IGF-1-induced ERK and Akt expression via the downregulation of IGF-1R expression and pro-apoptotic ERK activity. This evidence concerns the gene IGF1 and colonic neoplasm.